Authors:
NEUMAN MG
CAMERON RG
SHEAR NH
BELLENTANI S
TIRIBELLI C
Citation: Mg. Neuman et al., EFFECT OF TAUROURSODEOXYCHOLIC AND URSODEOXYCHOLIC ACID ON ETHANOL-INDUCED CELL INJURIES IN THE HUMAN HEP G2 CELL-LINE, Gastroenterology, 109(2), 1995, pp. 555-563
Citation: Sr. Knowles et Nh. Shear, ANAPHYLAXIS FROM BACITRACIN AND POLYMYXIN-B (POLYSPORIN) OINTMENT, International journal of dermatology, 34(8), 1995, pp. 572-573
Authors:
MITTMANN N
MITTER S
BORDEN EK
SHEAR NH
NARANJO CA
Citation: N. Mittmann et al., COMPARISON OF THE HAMILTON DEPRESSION RATING-SCALE AND THE MONTGOMERYASBERG DEPRESSION RATING-SCALE SCORES - IMPACT ON DEPRESSION RESEARCH, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 139-139
Authors:
MITTMANN N
SHEAR NH
EINARSON TR
NARANJO CA
Citation: N. Mittmann et al., ARE SELECTIVE SEROTONIN REUPTAKE INHIBITORS SUPERIOR TO TRICYCLIC ANTIDEPRESSANTS IN THE ELDERLY, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 200-200
Citation: Nh. Shear et Ak. Gupta, TERBINAFINE FOR THE TREATMENT OF PEDAL ONYCHOMYCOSIS - A FOOT CLOSER TO THE PROMISED LAND OF CURED NAILS, Archives of dermatology, 131(8), 1995, pp. 937-942
Citation: C. Spier et al., RECURRENT BEG ULCERATIONS AS THE INITIAL CLINICAL MANIFESTATION AT KLINEFELTERS-SYNDROME, Archives of dermatology, 131(2), 1995, pp. 230-230
Citation: Ak. Gupta et al., SPIRONOLACTONE-ASSOCIATED CUTANEOUS EFFECTS - A CASE-REPORT AND A REVIEW OF THE LITERATURE, Dermatology, 189(4), 1994, pp. 402-405
Authors:
PARKER KL
MITTMANN N
SHEAR NH
HERRMANN N
SHULMAN KI
SILVER IL
GARDNER DM
BUSTO UE
Citation: Kl. Parker et al., LITHIUM AUGMENTATION IN GERIATRIC DEPRESSED OUTPATIENTS - A CLINICAL REPORT, International journal of geriatric psychiatry, 9(12), 1994, pp. 995-1002
Authors:
NEUMAN NG
CAMERON RG
SHEAR NH
BELLENTANI S
TIRIBELLI C
Citation: Ng. Neuman et al., PROTECTIVE EFFECT TAUROURSODEOXYCHOLIC ACID (TUDCA) ON IN-VITRO ETHANOL-INDUCED CYTOTOXICITY IN HEP G2 CELLS, Hepatology, 20(4), 1994, pp. 10000313-10000313
Authors:
CAMERON RG
NEUMAN MG
SHEAR NH
BELLENTANI S
TIRIBELLI C
Citation: Rg. Cameron et al., IN-VITRO, IN HEP G2 CELL-LINE, TAUROURSODEOXYCHOLIC ACID HAS A PROTECTIVE EFFECT AGAINST ETHANOL-INDUCED HUMAN HEPATOCELLULAR DAMAGE, Hepatology, 20(4), 1994, pp. 10000336-10000336
Citation: Ea. Weber et al., DETECTION OF SULFAMETHOXAZOLE HYPERSENSITIVITY - SKIN TESTING WITH SULFAMETHOXAZOYL-POLY-L-TYROSINE, Journal of allergy and clinical immunology, 93(1), 1994, pp. 266-266
Citation: Kl. Lanctot et al., IMPROVING THE DIAGNOSIS OF HYPERSENSITIVITY REACTIONS ASSOCIATED WITHSULFONAMIDES, Journal of clinical pharmacology, 34(12), 1994, pp. 1228-1233
Citation: Ag. Recchia et Nh. Shear, ORGANIZATION AND FUNCTIONING OF AN ADVERSE DRUG REACTION CLINIC, Journal of clinical pharmacology, 34(1), 1994, pp. 68-79
Citation: Nh. Shear et al., XENOBIOTIC-INDUCED CYTOKINE PRODUCTION IN KERATINOCYTES AND HEPATOCYTES IN-VITRO IS DECREASED BY SILYMARIN AND PURPUROGALLIN, Journal of investigative dermatology, 102(4), 1994, pp. 646-646
Citation: Nh. Shear et al., SKIN AND LIVER CYTOPROTECTION BY SILYMARIN AGAINST ACETAMINOPHEN-INDUCED TOXICITY IN-VITRO, Journal of investigative dermatology, 102(4), 1994, pp. 647-647
Authors:
NARANJO CA
KWOK MCO
LANCTOT KL
ZHAO HP
SPIELBERG SP
SHEAR NH
Citation: Ca. Naranjo et al., ENHANCED DIFFERENTIAL-DIAGNOSIS OF ANTICONVULSANT HYPERSENSITIVITY REACTIONS BY AN INTEGRATED BAYESIAN AND BIOCHEMICAL APPROACH, Clinical pharmacology and therapeutics, 56(5), 1994, pp. 564-575
Citation: Mj. Rieder et al., METABOLIC BASIS FOR CROSS-SENSITIVITY BETWEEN SULFONAMIDES AND NITROFURANTOIN, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 154-154
Authors:
OH PI
KWOK M
SHEAR NH
LANCTOT KL
KNOWLES S
NARANJO CA
Citation: Pi. Oh et al., A COMPARISON OF METHODS FOR THE ASSESSMENT OF SUSPECTED ADVERSE DRUG REACTION IN THE CLINIC SETTING, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 156-156
Authors:
LIU BA
TOPPER AK
MAKI BE
GRYFE C
REEVES RA
SHEAR NH
Citation: Ba. Liu et al., FALLS IN THE ELDERLY - RELATIONSHIP TO MEDICATION USE AND ORTHOSTATICHYPOTENSION, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 173-173